improving Oncology investigation with built-in KRAS Assay products and services and RAS Assays
during the fast evolving industry of oncology investigate, exact and successful mutation screening is crucial for producing focused therapies. The KRAS solutions Platform performs a pivotal part In this particular landscape by offering comprehensive options for KRAS mutation profiling and analysis. KRAS mutations, located in around ninety five% of